Pharmacy, Natural & Health Sciences

Pharmacogenomics

 


Welcome from the Program Director

Thank you for taking time to learn more about MU's Master of Science in Pharmacogenomics (MS in PGx) Program.

Pharmacogenomics, the study of a patient’s response to medications relative to their genetics is a rapidly expanding component of precision medicine. The ability to look at an individual’s DNA and use that information to guide drug and/or drug dose selection can lead to more successful treatment, and reduce adverse drug reactions. Approximately 50% of patients do not respond optimally to the first drug they receive for a given need. Additionally, there are more than 750,000 serious adverse drug reactions with more than 120,000 deaths annually. Clearly, there is a role for pharmacogenomics in improving patient medication therapy.

Manchester University has recognized the need for education of applied scientists in PGx. In doing so, the University has designed a rigorous, innovative MS in PGx Program, provided in two delivery options, on-campus or online. The program underwent an extensive application process and is approved by the Higher Learning Commission.

The Master of Science in Pharmacogenomics Program graduates individuals of ability and conviction who benefit society through the application of pharmacogenomics in precision medicine.

Upon completion of our program, graduates will be able to:

  1. Demonstrate mastery of the scientific principles that relate to pharmacogenomics.
  2. Use literature and database resources to keep up-to-date with the evolving field of pharmacogenomics.
  3. Interpret pharmacogenomic test results and effectively communicate information in written and oral formats.
  4. Demonstrate technical proficiency with relevant instrumentation and methodologies.

It is clear that medicine is changing and Manchester University, through its MS in PGx Program is helping to lead that change. Upon completion of the program, it is our students that will help move individuals to better health. Thank you for visiting the Manchester MS in PGx website and for your interest in the program!

We invite you to explore the information presented here and contact us with any questions by emailing PGx@manchester.edu or by calling our Office of Student and Alumni Experience at 260-470-2703.

David_Kisor_Signature

 

 

David F. Kisor, BS, PharmD

Director of Pharmacogenomics Education

 

 
PGx Program Mission
The Master of Science in Pharmacogenomics Program graduates individuals of ability and conviction who benefit society through the application of pharmacogenomics in precision medicine.

Accreditation
The Manchester University Master of Science in Pharmacogenomics Program is accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools.


Non-Discrimination in the
Admission Process
The Manchester University Pharmacogenomics Program is committed to non-discrimination in the admissions process.The University does not discriminate on the basis of national origin, ancestry, race, color, age, sex, gender identity or expression, sexual orientation, familial status, religion, disability, physical characteristics, or veteran status in admissions including its admission decisions and scholarships or loan awards.